Colchicine and/or Naltrexone for Hospitalized COVID-19 Patients Not Requiring High Levels of Ventilatory Support (COLTREXONE): A Prospective, Randomized, Open-Label Trial

{ 'indexed': {'date-parts': [[2024, 5, 16]], 'date-time': '2024-05-16T00:36:43Z', 'timestamp': 1715819803289}, 'reference-count': 26, 'publisher': 'Springer Science and Business Media LLC', 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2024, 5, 15]]}, 'DOI': '10.7759/cureus.60364', 'type': 'journal-article', 'created': {'date-parts': [[2024, 5, 15]], 'date-time': '2024-05-15T19:31:40Z', 'timestamp': 1715801500000}, 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Colchicine and/or Naltrexone for Hospitalized COVID-19 Patients Not Requiring High Levels of ' 'Ventilatory Support (COLTREXONE): A Prospective, Randomized, Open-Label Trial', 'prefix': '10.7759', 'author': [ {'given': 'Elie', 'family': 'Gertner', 'sequence': 'first', 'affiliation': []}, {'given': 'Anne', 'family': 'Schullo-Feulner', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alison', 'family': 'Knutson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ella', 'family': 'Chrenka', 'sequence': 'additional', 'affiliation': []}, {'given': 'Meghan', 'family': "O'Brien", 'sequence': 'additional', 'affiliation': []}, {'given': 'Christine', 'family': 'Behrendt', 'sequence': 'additional', 'affiliation': []}, {'given': 'Joseph', 'family': 'Johnson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Daniel', 'family': 'Delaney', 'sequence': 'additional', 'affiliation': []}], 'member': '297', 'reference': [ { 'key': 'ref1', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/S0140-6736(20)30628-0', 'article-title': 'COVID-19: consider cytokine storm syndromes and immunosuppression', 'volume': '395', 'author': 'Mehta P', 'year': '2020', 'unstructured': 'Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. ' 'COVID-19: consider cytokine storm syndromes and immunosuppression. ' 'Lancet. 2020, 395:1033-4. 10.1016/S0140-6736(20)30628-0', 'journal-title': 'Lancet'}, { 'key': 'ref2', 'doi-asserted-by': 'publisher', 'DOI': '10.1080/22221751.2020.1746199', 'article-title': 'Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review ' 'of immune changes in patients with viral pneumonia', 'volume': '9', 'author': 'Lin L', 'year': '2020', 'unstructured': 'Lin L, Lu L, Cao W, Li T. Hypothesis for potential pathogenesis of ' 'SARS-CoV-2 infection-a review of immune changes in patients with viral ' 'pneumonia. Emerg Microbes Infect. 2020, 9:727-32. ' '10.1080/22221751.2020.1746199', 'journal-title': 'Emerg Microbes Infect'}, { 'key': 'ref3', 'doi-asserted-by': 'publisher', 'DOI': '10.1001/jamainternmed.2020.0994', 'article-title': 'Risk factors associated with acute respiratory distress syndrome and ' 'death in patients with coronavirus disease 2019 pneumonia in Wuhan, ' 'China', 'volume': '180', 'author': 'Wu C', 'year': '2020', 'unstructured': 'Wu C, Chen X, Cai Y, et al.. Risk factors associated with acute ' 'respiratory distress syndrome and death in patients with coronavirus ' 'disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020, ' '180:934-43. 10.1001/jamainternmed.2020.0994', 'journal-title': 'JAMA Intern Med'}, { 'key': 'ref4', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.jacc.2020.04.031', 'article-title': 'COVID-19 and thrombotic or thromboembolic disease: implications for ' 'prevention, antithrombotic therapy, and follow-up: JACC ' 'state-of-the-art review', 'volume': '75', 'author': 'Bikdeli B', 'year': '2020', 'unstructured': 'Bikdeli B, Madhavan MV, Jimenez D, et al.. COVID-19 and thrombotic or ' 'thromboembolic disease: implications for prevention, antithrombotic ' 'therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol. ' '2020, 75:2950-73. 10.1016/j.jacc.2020.04.031', 'journal-title': 'J Am Coll Cardiol'}, { 'key': 'ref5', 'doi-asserted-by': 'publisher', 'DOI': '10.4103/HEARTVIEWS.HEARTVIEWS_154_20', 'article-title': 'Myocarditis and pericarditis in patients with COVID-19', 'volume': '21', 'author': 'Shah JZ', 'year': '2020', 'unstructured': 'Shah JZ, Kumar SA, Patel AA. Myocarditis and pericarditis in patients ' 'with COVID-19. Heart Views. 2020, 21:209-14. ' '10.4103/HEARTVIEWS.HEARTVIEWS_154_20', 'journal-title': 'Heart Views'}, { 'key': 'ref6', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.semarthrit.2015.06.013', 'article-title': 'Colchicine--Update on mechanisms of action and therapeutic uses', 'volume': '45', 'author': 'Leung YY', 'year': '2015', 'unstructured': 'Leung YY, Yao Hui LL, Kraus VB. Colchicine--Update on mechanisms of ' 'action and therapeutic uses. Semin Arthritis Rheum. 2015, 45:341-50. ' '10.1016/j.semarthrit.2015.06.013', 'journal-title': 'Semin Arthritis Rheum'}, { 'key': 'ref7', 'doi-asserted-by': 'publisher', 'DOI': '10.1056/NEJMoa1912388', 'article-title': 'Efficacy and safety of low-dose colchicine after myocardial infarction', 'volume': '381', 'author': 'Tardif JC', 'year': '2019', 'unstructured': 'Tardif JC, Kouz S, Waters DD, et al.. Efficacy and safety of low-dose ' 'colchicine after myocardial infarction. N Engl J Med. 2019, ' '381:2497-505. 10.1056/NEJMoa1912388', 'journal-title': 'N Engl J Med'}, { 'key': 'ref8', 'doi-asserted-by': 'publisher', 'DOI': '10.2459/JCM.0000000000001059', 'article-title': 'Anti-inflammatory therapies for pericardial diseases in the COVID-19 ' 'pandemic: safety and potentiality', 'volume': '21', 'author': 'Imazio M', 'year': '2020', 'unstructured': 'Imazio M, Brucato A, Lazaros G, et al.. Anti-inflammatory therapies for ' 'pericardial diseases in the COVID-19 pandemic: safety and potentiality. ' 'J Cardiovasc Med (Hagerstown). 2020, 21:625-9. ' '10.2459/JCM.0000000000001059', 'journal-title': 'J Cardiovasc Med (Hagerstown)'}, { 'key': 'ref9', 'doi-asserted-by': 'publisher', 'DOI': '10.1186/s12969-021-00588-0', 'article-title': 'Colchicine - an effective treatment for children with a clinical ' 'diagnosis of autoinflammatory diseases without pathogenic gene variants', 'volume': '19', 'author': 'Welzel T', 'year': '2021', 'unstructured': 'Welzel T, Wildermuth AL, Deschner N, Benseler SM, Kuemmerle-Deschner JB. ' 'Colchicine - an effective treatment for children with a clinical ' 'diagnosis of autoinflammatory diseases without pathogenic gene variants. ' 'Pediatr Rheumatol Online J. 2021, 19:142. 10.1186/s12969-021-00588-0', 'journal-title': 'Pediatr Rheumatol Online J'}, { 'key': 'ref10', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.rmed.2021.106322', 'article-title': 'Colchicine and SARS-CoV-2: management of the hyperinflammatory state', 'volume': '178', 'author': 'Vitiello A', 'year': '2021', 'unstructured': 'Vitiello A, Ferrara F. Colchicine and SARS-CoV-2: management of the ' 'hyperinflammatory state. Respir Med. 2021, 178:106322. ' '10.1016/j.rmed.2021.106322', 'journal-title': 'Respir Med'}, { 'key': 'ref11', 'doi-asserted-by': 'publisher', 'DOI': '10.1080/00498254.2021.1909782', 'article-title': 'Colchicine for the treatment of COVID-19 patients: efficacy, safety, ' 'and model informed dosage regimens', 'volume': '51', 'author': 'Karatza E', 'year': '2021', 'unstructured': 'Karatza E, Ismailos G, Karalis V. Colchicine for the treatment of ' 'COVID-19 patients: efficacy, safety, and model informed dosage regimens. ' 'Xenobiotica. 2021, 51:643-56. 10.1080/00498254.2021.1909782', 'journal-title': 'Xenobiotica'}, { 'key': 'ref12', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s00011-022-01540-y', 'article-title': 'Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt ' 'hyperinflammation', 'volume': '71', 'author': 'Bonaventura A', 'year': '2022', 'unstructured': 'Bonaventura A, Vecchié A, Dagna L, Tangianu F, Abbate A, Dentali F. ' 'Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt ' 'hyperinflammation. Inflamm Res. 2022, 71:293-307. ' '10.1007/s00011-022-01540-y', 'journal-title': 'Inflamm Res'}, { 'key': 'ref13', 'doi-asserted-by': 'publisher', 'DOI': '10.1378/chest.120.4.1301', 'article-title': 'Initial evidence of endothelial cell apoptosis as a mechanism of ' 'systemic capillary leak syndrome', 'volume': '120', 'author': 'Assaly R', 'year': '2001', 'unstructured': 'Assaly R, Olson D, Hammersley J, Fan PS, Liu J, Shapiro JI, Kahaleh MB. ' 'Initial evidence of endothelial cell apoptosis as a mechanism of ' 'systemic capillary leak syndrome. Chest. 2001, 120:1301-8. ' '10.1378/chest.120.4.1301', 'journal-title': 'Chest'}, { 'key': 'ref14', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/jcm10215128', 'article-title': 'Immunologic dysregulation and hypercoagulability as a pathophysiologic ' 'background in COVID-19 infection and the immunomodulating role of ' 'colchicine', 'volume': '10', 'author': 'Vrachatis DA', 'year': '2021', 'unstructured': 'Vrachatis DA, Papathanasiou KA, Giotaki SG, et al.. Immunologic ' 'dysregulation and hypercoagulability as a pathophysiologic background in ' 'COVID-19 infection and the immunomodulating role of colchicine. J Clin ' 'Med. 2021, 10:5128. 10.3390/jcm10215128', 'journal-title': 'J Clin Med'}, { 'key': 'ref15', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.clim.2020.108490', 'article-title': 'Treating COVID-19 with colchicine in community healthcare setting', 'volume': '217', 'author': 'Della-Torre E', 'year': '2020', 'unstructured': 'Della-Torre E, Della-Torre F, Kusanovic M, Scotti R, Ramirez GA, Dagna ' 'L, Tresoldi M. Treating COVID-19 with colchicine in community healthcare ' 'setting. Clin Immunol. 2020, 217:108490. 10.1016/j.clim.2020.108490', 'journal-title': 'Clin Immunol'}, { 'key': 'ref16', 'doi-asserted-by': 'publisher', 'DOI': '10.1001/jamanetworkopen.2020.13136', 'article-title': 'Effect of colchicine vs standard care on cardiac and inflammatory ' 'biomarkers and clinical outcomes in patients hospitalized with ' 'coronavirus disease 2019; the GRECCO-19 randomized clinical trial', 'volume': '3', 'author': 'Deftereos SG', 'year': '2020', 'unstructured': 'Deftereos SG, Giannopoulos G, Vrachatis DA, et al.. Effect of colchicine ' 'vs standard care on cardiac and inflammatory biomarkers and clinical ' 'outcomes in patients hospitalized with coronavirus disease 2019; the ' 'GRECCO-19 randomized clinical trial. JAMA Netw Open. 2020, 3:e2013136. ' '10.1001/jamanetworkopen.2020.13136', 'journal-title': 'JAMA Netw Open'}, { 'key': 'ref17', 'doi-asserted-by': 'publisher', 'DOI': '10.1136/rmdopen-2020-001455', 'article-title': 'Beneficial effects of colchicine for moderate to severe COVID-19: a ' 'randomised, double-blinded, placebo-controlled clinical trial', 'volume': '7', 'author': 'Lopes MI', 'year': '2021', 'unstructured': 'Lopes MI, Bonjorno LP, Giannini MC, et al.. Beneficial effects of ' 'colchicine for moderate to severe COVID-19: a randomised, ' 'double-blinded, placebo-controlled clinical trial. RMD Open. 2021, ' '7:10.1136/rmdopen-2020-001455', 'journal-title': 'RMD Open'}, { 'key': 'ref18', 'doi-asserted-by': 'publisher', 'DOI': '10.1136/annrheumdis-2020-217712', 'article-title': 'Association between treatment with colchicine and improved survival in ' 'a single-centre cohort of adult hospitalised patients with COVID-19 ' 'pneumonia and acute respiratory distress syndrome', 'volume': '79', 'author': 'Scarsi M', 'year': '2020', 'unstructured': 'Scarsi M, Piantoni S, Colombo E, et al.. Association between treatment ' 'with colchicine and improved survival in a single-centre cohort of adult ' 'hospitalised patients with COVID-19 pneumonia and acute respiratory ' 'distress syndrome. Ann Rheum Dis. 2020, 79:1286-9. ' '10.1136/annrheumdis-2020-217712', 'journal-title': 'Ann Rheum Dis'}, { 'key': 'ref19', 'doi-asserted-by': 'publisher', 'DOI': '10.1155/2020/8865954', 'article-title': 'A case control study to evaluate the impact of colchicine on patients ' 'admitted to the hospital with moderate to severe COVID-19 infection', 'volume': '2020', 'author': 'Sandhu T', 'year': '2020', 'unstructured': 'Sandhu T, Tieng A, Chilimuri S, Franchin G. A case control study to ' 'evaluate the impact of colchicine on patients admitted to the hospital ' 'with moderate to severe COVID-19 infection. Can J Infect Dis Med ' 'Microbiol. 2020, 2020:8865954. 10.1155/2020/8865954', 'journal-title': 'Can J Infect Dis Med Microbiol'}, { 'key': 'ref20', 'doi-asserted-by': 'publisher', 'DOI': '10.31138/mjr.33.2.232', 'article-title': 'The impact of colchicine on COVID-19 patients: a clinical trial study', 'volume': '33', 'author': 'Salehzadeh F', 'year': '2022', 'unstructured': 'Salehzadeh F, Pourfarzi F, Ataei S. The impact of colchicine on COVID-19 ' 'patients: a clinical trial study. Mediterr J Rheumatol. 2022, 33:232-6. ' '10.31138/mjr.33.2.232', 'journal-title': 'Mediterr J Rheumatol'}, { 'key': 'ref21', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/medsci6040082', 'article-title': 'Low-dose naltrexone (LDN)-review of therapeutic utilization', 'volume': '6', 'author': 'Toljan K', 'year': '2018', 'unstructured': 'Toljan K, Vrooman B. Low-dose naltrexone (LDN)-review of therapeutic ' 'utilization. Med Sci (Basel). 2018, 6:82. 10.3390/medsci6040082', 'journal-title': 'Med Sci (Basel)'}, { 'key': 'ref22', 'doi-asserted-by': 'publisher', 'DOI': '10.1080/07391102.2020.1820379', 'article-title': 'Naltrexone a potential therapeutic candidate for COVID-19', 'volume': '40', 'author': 'Choubey A', 'year': '2022', 'unstructured': 'Choubey A, Dehury B, Kumar S, Medhi B, Mondal P. Naltrexone a potential ' 'therapeutic candidate for COVID-19. J Biomol Struct Dyn. 2022, ' '40:963-70. 10.1080/07391102.2020.1820379', 'journal-title': 'J Biomol Struct Dyn'}, { 'key': 'ref23', 'doi-asserted-by': 'publisher', 'DOI': '10.1001/jamanetworkopen.2021.41328', 'article-title': 'Effect of colchicine vs usual care alone on intubation and 28-day ' 'mortality in patients hospitalized with COVID-19: a randomized clinical ' 'trial', 'volume': '4', 'author': 'Diaz R', 'year': '2021', 'unstructured': 'Diaz R, Orlandini A, Castellana N, et al.. Effect of colchicine vs usual ' 'care alone on intubation and 28-day mortality in patients hospitalized ' 'with COVID-19: a randomized clinical trial. JAMA Netw Open. 2021, ' '4:e2141328. 10.1001/jamanetworkopen.2021.41328', 'journal-title': 'JAMA Netw Open'}, { 'key': 'ref24', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/S2213-2600(21)00435-5', 'article-title': 'Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a ' 'randomised, controlled, open-label, platform trial', 'volume': '9', 'year': '2021', 'unstructured': 'Colchicine in patients admitted to hospital with COVID-19 (RECOVERY). a ' 'randomised, controlled, open-label, platform trial. Lancet Respir Med. ' '2021, 9:1419-26. 10.1016/S2213-2600(21)00435-5', 'journal-title': 'Lancet Respir Med'}, { 'key': 'ref25', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/14651858.CD015045', 'article-title': 'Colchicine for the treatment of COVID-19', 'volume': '10', 'author': 'Mikolajewska A', 'year': '2021', 'unstructured': 'Mikolajewska A, Fischer AL, Piechotta V, et al.. Colchicine for the ' 'treatment of COVID-19. Cochrane Database Syst Rev. 2021, 10:CD015045. ' '10.1002/14651858.CD015045', 'journal-title': 'Cochrane Database Syst Rev'}, { 'key': 'ref26', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/iid3.562', 'article-title': 'The effect of colchicine on mortality outcome and duration of hospital ' 'stay in patients with COVID-19: a meta-analysis of randomized trials', 'volume': '10', 'author': 'Kow CS', 'year': '2022', 'unstructured': 'Kow CS, Lee LH, Ramachandram DS, Hasan SS, Ming LC, Goh HP. The effect ' 'of colchicine on mortality outcome and duration of hospital stay in ' 'patients with COVID-19: a meta-analysis of randomized trials. Immun ' 'Inflamm Dis. 2022, 10:255-64. 10.1002/iid3.562', 'journal-title': 'Immun Inflamm Dis'}], 'container-title': 'Cureus', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://www.cureus.com/articles/240800-colchicine-andor-naltrexone-for-hospitalized-covid-19-patients-not-requiring-high-levels-of-ventilatory-support-coltrexone-a-prospective-randomized-open-label-trial', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2024, 5, 15]], 'date-time': '2024-05-15T19:31:44Z', 'timestamp': 1715801504000}, 'score': 1, 'resource': { 'primary': { 'URL': 'https://www.cureus.com/articles/240800-colchicine-andor-naltrexone-for-hospitalized-covid-19-patients-not-requiring-high-levels-of-ventilatory-support-coltrexone-a-prospective-randomized-open-label-trial'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2024, 5, 15]]}, 'references-count': 26, 'URL': 'http://dx.doi.org/10.7759/cureus.60364', 'relation': {}, 'ISSN': ['2168-8184'], 'subject': [], 'published': {'date-parts': [[2024, 5, 15]]}}